Angelopoulou, M. K., Vassilakopoulos, T. P., Batsis, I., Sakellari, I., Gkirkas, K., Pappa, V., Giannoulia, P., Apostolidis, I., Apostolopoulos, C., Roussou, P., Panayiotidis, P., Dimou, M., Kyrtsonis, M., Palassopoulou, M., Vassilopoulos, G., Moschogiannis, M., Kalpadakis, C., Margaritis, D., Spyridonidis, A., Michalis, E., Anargyrou, K., Repousis, P., Hatzimichael, E., Bousiou, Z., Poulakidas, E., Grentzelias, D., Harhalakis, N., Pangalis, G. A., Anagnostopoulos, A., & Tsirigotis, P. (2018). brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. Hematological oncology, 36(1), 174–181. http://access.bl.uk/ark:/81055/vdc_100066048826.0x000050